BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 9:55:00 AM | Browse: 848 | Download: 645
Publication Name World Journal of Gastroenterology
Manuscript ID 1107
Country/Territory Poland
Received
2012-11-12 00:23
Peer-Review Started
2012-11-12 14:09
To Make the First Decision
2013-03-04 13:41
Return for Revision
2013-03-05 09:19
Revised
2013-03-08 20:46
Second Decision
2013-04-09 20:15
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-04-10 07:29
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-05-17 20:29
Publish the Manuscript Online
2013-05-28 09:36
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Autobiography
Article Title Glucomannan for abdominal pain-related functional gastrointestinal disorders in children: A randomized trial
Manuscript Source Invited Manuscript
All Author List Andrea Horvath, Piotr Dziechciarz and Hania Szajewska
Funding Agency and Grant Number
Corresponding Author Dr. Andrea Horvath, Department of Paediatrics, the Medical University of Warsaw, 01-184 Warsaw, Dzialdowska 1, Poland. andrea.hania@gmail.com
Key Words Functional abdominal pain; Abdominal pain-related functional gastrointestinal disorders; Children
Core Tip This study focused on abdominal pain-related functional gastrointestinal disorders (FGIDs) which are a common problem in children. The aim of the study was to assess the effectiveness of glucomannan (GNN), a soluble fiber of the Japanese Konjac plant, in alleviating the frequency and the severity of pain in children with FGIDs. We have demonstrated through our prospective, double-blind, placebo-controlled, randomized study that GNN in this setting for 4 wk was not effective in treatment of the FGIDs. The obtained results led us to the conclusion that further studies are needed to explore the role of GNN in the pathophysiology of functional disorders.
Publish Date 2013-05-28 09:36
Citation Horvath A, Dziechciarz P, Szajewska H. Glucomannan for abdominal pain-related functional gastrointestinal disorders in children: A randomized trial. World J Gastroenterol 2013; 19(20): 3062-3068
URL http://www.wjgnet.com/1007-9327/full/v19/i20/3062.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i20.3062
Full Article (PDF) WJG-19-3062.pdf
Manuscript File 1107-Review.docx
Answering Reviewers 1107-Answering reviewers.docx
Copyright License Agreement 1107-Copyright assignment.docx
Non-Native Speakers of English Editing Certificate 1107-Language certificate.pdf
Peer-review Report 1107-Peer review(s).pdf
Scientific Editor Work List 1107-Scientific editor work list.doc